Lottenberg R - Search Results

1

A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.

Smith WR, McClish DK, Lottenberg R, Sisler IY, Sop D, Johnson S, Villella A, Liles D, Yang E, Chen I. Smith WR, et al. Among authors: lottenberg r. Br J Haematol. 2022 Jan;196(1):193-203. doi: 10.1111/bjh.17952. Epub 2021 Nov 16. Br J Haematol. 2022. PMID: 34786695 Clinical Trial.

2

Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.

Zumberg MS, Reddy S, Boyette RL, Schwartz RJ, Konrad TR, Lottenberg R. Zumberg MS, et al. Among authors: lottenberg r. Am J Hematol. 2005 Jun;79(2):107-13. doi: 10.1002/ajh.20353. Am J Hematol. 2005. PMID: 15929107 Free article.

3

Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell disease.

LaVista JM, Treise DM, Dunbar LN, Ritho J, Hartzema AG, Lottenberg R. LaVista JM, et al. Among authors: lottenberg r. J Natl Med Assoc. 2009 Mar;101(3):251-7. doi: 10.1016/s0027-9684(15)30853-1. J Natl Med Assoc. 2009. PMID: 19331257

4

Hydroxyurea use in patients with sickle cell disease in a Medicaid population.

Ritho J, Liu H, Hartzema AG, Lottenberg R. Ritho J, et al. Among authors: lottenberg r. Am J Hematol. 2011 Oct;86(10):888-90. doi: 10.1002/ajh.22134. Epub 2011 Aug 22. Am J Hematol. 2011. PMID: 21922530 Free article. No abstract available.

5

Update on the use of hydroxyurea therapy in sickle cell disease.

Wong TE, Brandow AM, Lim W, Lottenberg R. Wong TE, et al. Among authors: lottenberg r. Blood. 2014 Dec 18;124(26):3850-7; quiz 4004. doi: 10.1182/blood-2014-08-435768. Epub 2014 Oct 6. Blood. 2014. PMID: 25287707 Free PMC article. Review. No abstract available.

6

Approach to the diagnosis and treatment of acute subarachnoid hemorrhage in a patient with sickle cell disease.

Lyon M, Jeter J, Lottenberg R. Lyon M, et al. Among authors: lottenberg r. Am J Emerg Med. 2015 Mar;33(3):481.e3-4. doi: 10.1016/j.ajem.2014.08.068. Epub 2014 Aug 29. Am J Emerg Med. 2015. PMID: 25256268

7

Opportunities to improve outcomes in sickle cell disease.

Mehta SR, Afenyi-Annan A, Byrns PJ, Lottenberg R. Mehta SR, et al. Among authors: lottenberg r. Am Fam Physician. 2006 Jul 15;74(2):303-10. Am Fam Physician. 2006. PMID: 16883928 Free article. Review.

8

Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.

Murphy M, Close J, Lottenberg R, Rajasekhar A. Murphy M, et al. Among authors: lottenberg r. Am J Med Sci. 2014 Mar;347(3):254-5. doi: 10.1097/MAJ.0000000000000228. Am J Med Sci. 2014. PMID: 24553361 No abstract available.

9

Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.

Dunbar LN, Coleman Brown L, Rivera DR, Hartzema AG, Lottenberg R. Dunbar LN, et al. Among authors: lottenberg r. ISRN Hematol. 2012;2012:524513. doi: 10.5402/2012/524513. Epub 2012 Dec 12. ISRN Hematol. 2012. PMID: 23316379 Free PMC article.

10

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J. Yawn BP, et al. Among authors: lottenberg r. JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517. JAMA. 2014. PMID: 25203083 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page